 IRVINE, Calif., Dec. 15, 2020 GLOBE NEWSWIRE -- Oncocyte Corporation NYSE American: OCX, a molecular diagnostics company with a mission to provide actionable answers at critical decision points across the cancer care continuum, announced today that management is scheduled to present at the 13th Annual LD Micro Main Event Conference. 